Fluicell publishes 2023 Half-year report
Today, August 2023, Fluicell publishes the financial report for the period January 1 to June 30, 2023. The…
Today, August 2023, Fluicell publishes the financial report for the period January 1 to June 30, 2023. The…
The cell microenvironment plays a key role in many biological processes. Replicating the cell microenvironment and the complex…
Premenstrual dysphoric disorder (PMDD) is a mood disorder affecting up to 8% of all menstruating women that greatly…
Changing research at the core has been a driving force for us at Fluicell from the start. Through…
Updtae 2023-05-23 All the talks from the Capital Markets Day are now available here: https://fluicell.com/capital-markets-day-2023/. You can also…
Our plan is to continue to advance in all our three business areas: research solutions, human in vitro…
Fluicell’s type 1 diabetes development program is aimed at creating patient-tailored artificial pancreatic islets capable of enabling glycemic…
Today, May 12 2023, Fluicell publishes the Q1 interim report for the period January to March, 2023. The…
We at Fluicell are passionate about research and science and always want to take the opportunity to inspire…